144 related articles for article (PubMed ID: 22641675)
21. Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.
Yamamoto N; Naraparaju VR
Immunol Cell Biol; 1998 Jun; 76(3):237-44. PubMed ID: 9682967
[TBL] [Abstract][Full Text] [Related]
22. Characterization of human Gc protein-derived macrophage activation factor (GcMAF) and its functional role in macrophage tumoricidal activity.
Mohamad SB; Hori H; Nagasawa H; Usui K; Uto Y
Adv Exp Med Biol; 2003; 510():77-82. PubMed ID: 12580408
[No Abstract] [Full Text] [Related]
23. Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF).
Yamamoto N; Ushijima N; Koga Y
J Med Virol; 2009 Jan; 81(1):16-26. PubMed ID: 19031451
[TBL] [Abstract][Full Text] [Related]
24. Mitogen-activated protein kinase pathway mediates DBP-maf-induced apoptosis in RAW 264.7 macrophages.
Gumireddy K; Reddy CD; Swamy N
J Cell Biochem; 2003 Sep; 90(1):87-96. PubMed ID: 12938159
[TBL] [Abstract][Full Text] [Related]
25. Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells.
Pacini S; Punzi T; Morucci G; Gulisano M; Ruggiero M
Anticancer Res; 2012 Jan; 32(1):45-52. PubMed ID: 22213287
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.
Koga Y; Naraparaju VR; Yamamoto N
Proc Soc Exp Biol Med; 1999 Jan; 220(1):20-6. PubMed ID: 9893164
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
Yamamoto N; Homma S
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8539-43. PubMed ID: 1924312
[TBL] [Abstract][Full Text] [Related]
28. Structural definition of a potent macrophage activating factor derived from vitamin D3-binding protein with adjuvant activity for antibody production.
Yamamoto N
Mol Immunol; 1996 Oct; 33(15):1157-64. PubMed ID: 9070663
[TBL] [Abstract][Full Text] [Related]
29. The glycosylation and characterization of the candidate Gc macrophage activating factor.
Ravnsborg T; Olsen DT; Thysen AH; Christiansen M; Houen G; Højrup P
Biochim Biophys Acta; 2010 Apr; 1804(4):909-17. PubMed ID: 20079467
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.
Yamamoto N; Homma S; Haddad JG; Kowalski MA
Immunology; 1991 Nov; 74(3):420-4. PubMed ID: 1769691
[TBL] [Abstract][Full Text] [Related]
31. Effect of salivary gland adenocarcinoma cell-derived alpha-N-acetylgalactosaminidase on the bioactivity of macrophage activating factor.
Matsuura T; Uematsu T; Yamaoka M; Furusawa K
Int J Oncol; 2004 Mar; 24(3):521-8. PubMed ID: 14767536
[TBL] [Abstract][Full Text] [Related]
32. Modification of alpha 2-macroglobulin into a macrophage-activating factor through the action of liposome-stimulated B-cell membranous glycosidases.
Murai M; Aramaki Y; Tsuchiya S
Immunology; 1995 Sep; 86(1):58-63. PubMed ID: 7590882
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D binding protein-macrophage activating factor inhibits HCC in SCID mice.
Nonaka K; Onizuka S; Ishibashi H; Uto Y; Hori H; Nakayama T; Matsuura N; Kanematsu T; Fujioka H
J Surg Res; 2012 Jan; 172(1):116-22. PubMed ID: 20855083
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
Yamamoto N; Naraparaju VR
Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the Biological Properties of Blood Plasma Protein with GcMAF Functional Activity.
Dolgova EV; Kirikovich SS; Levites EV; Ruzanova VS; Proskurina AS; Ritter GS; Taranov OS; Varaksin NA; Ryabicheva TG; Leplina OY; Ostanin AA; Chernykh ER; Bogachev SS
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897653
[TBL] [Abstract][Full Text] [Related]
36. Glycan structure of Gc Protein-derived Macrophage Activating Factor as revealed by mass spectrometry.
Borges CR; Rehder DS
Arch Biochem Biophys; 2016 Sep; 606():167-79. PubMed ID: 27503803
[TBL] [Abstract][Full Text] [Related]
37. Phenotype of Gc-globulin influences the macrophage activating factor (MAF) levels in serum.
Debruyne E; Speeckaert M; Weygaerde YV; Delanghe J
Clin Chem Lab Med; 2011 Nov; 49(11):1855-60. PubMed ID: 21859424
[TBL] [Abstract][Full Text] [Related]
38. Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis.
Yamamoto N; Naraparaju VR; Orchard PJ
Blood; 1996 Aug; 88(4):1473-8. PubMed ID: 8695868
[TBL] [Abstract][Full Text] [Related]
39. Oral Colostrum Macrophage-activating Factor for Serious Infection and Chronic Fatigue Syndrome: Three Case Reports.
Inui T; Kubo K; Kuchiike D; Uto Y; Nishikata T; Sakamoto N; Mette M
Anticancer Res; 2015 Aug; 35(8):4545-9. PubMed ID: 26168499
[TBL] [Abstract][Full Text] [Related]
40. Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.
Mohamad SB; Nagasawa H; Uto Y; Hori H
Comp Biochem Physiol A Mol Integr Physiol; 2002 May; 132(1):1-8. PubMed ID: 12062184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
